| Title: | Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes |
| Authors: | Mannering, SI Di Carluccio, AR Elso, CM |
| Issue Year: | 2019 |
| Publisher | SPRINGER |
| Series | Diabetologia: |
| Abstract | Type 1 diabetes is an autoimmune disease caused by T cell-mediated destruction of pancreatic insulin-producing beta cells. The epitopes recognised by pathogenic T cells in human type 1 diabetes are poorly defined; however, a growing body of evidence suggests that T cell responses against neoepitopes contribute to beta cell destruction in type 1 diabetes. Neoepitopes are formed when self-proteins undergo post-translational modification to create a new epitope that is recognised by T- or B cells. Here we review the role of human T cell responses against neoepitopes in the immune pathogenesis of type 1 diabetes. Specifically, we review the different approaches to identifying neoepitopes relevant to human type 1 diabetes and outline several advances in this field that have occurred over the past few years. We also discuss the application of neoepitopes to the development of antigen-specific therapies for type 1 diabetes and the unresolved challenges that need to be overcome before the full repertoire of neoepitopes recognised by pathogenic human T cells in type 1 diabetes can be determined. This information may then be used to develop antigen-specific therapies for type 1 diabetes and assays to monitor changes in pathogenic, beta cell-specific T cell responses. |
| URI: | https://publications.svi.edu.au/publications/2575 |
| Other Identifiers | 10.1007/s00125-018-4760-6 |
| Publication type | Review |